Prefrontal Neurovascular Coupling Abnormalities Associated With Cognitive Performance in Multiple Sclerosis
CNS Neuroscience & Therapeutics · 2026-09 · 32 (9)
DOI: 10.1002/cns.71124 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 31.08.2026. Verfasst von Ruisi Gong und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, The First Hospital of China Medical University, Shenyang, Liaoning, China. Hauptthemen laut MEDLINE: Prefrontal Cortex, Multiple Sclerosis, Neurovascular Coupling, Cognition Disorders. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Project of Liaoning Province, China, National Innovation Center for Advanced Medical Devices.
Abstract (Originalsprache)
Background
Cognitive impairment is a prevalent and debilitating feature in multiple sclerosis (MS), yet its pathophysiology remains incompletely understood. Dysfunction of the neurovascular unit (NVU) and impaired neurovascular coupling (NVC) may be related to cognitive performance in MS, but this pathway remains insufficiently studied. This study investigated whether NVC abnormalities are associated with cognitive performance in MS.
Methods
Ninety‐seven MS patients and 83 healthy controls (HCs) underwent resting‐state functional magnetic resonance imaging (rs‐fMRI) and arterial spin labeling (ASL) perfusion MRI acquisition. The amplitude of low‐frequency fluctuations (ALFF) was used as an index of regional spontaneous neuronal activity, and cerebral blood flow (CBF) was quantified. NVC was quantified globally (CBF‐ALFF correlation) and regionally (CBF/ALFF ratio). We analyzed the correlations between regional NVC metrics and cognitive performance and Expanded Disability Status Scale (EDSS) scores. Sensitivity analyses tested robustness across alternative functional metrics, gray matter volume (GMV), T2 lesion volume, disability severity, treatment status, and the relapsing‐remitting multiple sclerosis (RRMS) subgroup.
Results
Compared with HCs, MS patients demonstrated (1) reduced CBF‐ALFF coupling in the ALFF‐based analysis, and (2) increased CBF/ALFF ratios in the bilateral medial prefrontal cortex (mPFC). The regional mPFC finding, particularly on the left, remained robust across sensitivity analyses and was associated with worse cognitive performance and higher EDSS scores.
Conclusion
These findings suggest altered NVC in MS, with regional prefrontal abnormalities representing the most robust and clinically relevant finding. Regional prefrontal NVC abnormalities may provide a potential imaging correlate of cognitive performance in MS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, The First Hospital of China Medical University, Shenyang, Liaoning, China.
- Department of Neurology, The First Hospital of China Medical University, Shenyang, Liaoning, China.
ORCID-Profile: Xiaohan Xu, Hefei Fu, Lingling Cui
Förderung
- Science and Technology Project of Liaoning Province, China
- National Innovation Center for Advanced Medical Devices
Zitieren
APA
Gong, R., Zhang, H., Jiao, J., Liu, L., Xu, X., Song, H., Zhou, Y., Duan, Y., Fu, H., Cao, J., & Cui, L. (2026). Prefrontal Neurovascular Coupling Abnormalities Associated With Cognitive Performance in Multiple Sclerosis. CNS Neuroscience & Therapeutics, 32(9). https://doi.org/10.1002/cns.71124
Vancouver
Gong R, Zhang H, Jiao J, Liu L, Xu X, Song H, et al. Prefrontal Neurovascular Coupling Abnormalities Associated With Cognitive Performance in Multiple Sclerosis. CNS Neuroscience & Therapeutics. 2026;32(9). doi:10.1002/cns.71124
BibTeX
@article{Gong2026,
author = {Gong, Ruisi and Zhang, Hao and Jiao, Jinlin and Liu, Lei and Xu, Xiaohan and Song, Huiwen and Zhou, Yuexin and Duan, Yuanjie and Fu, Hefei and Cao, Jibin and Cui, Lingling},
title = {Prefrontal Neurovascular Coupling Abnormalities Associated With Cognitive Performance in Multiple Sclerosis},
journal = {CNS Neuroscience & Therapeutics},
year = {2026},
volume = {32},
number = {9},
doi = {10.1002/cns.71124}
}
EUVIMED